These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis]. Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194 [TBL] [Abstract][Full Text] [Related]
3. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Topol EJ; Lancet; 2001 Jun; 357(9272):1905-14. PubMed ID: 11425410 [TBL] [Abstract][Full Text] [Related]
4. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis]. Vandoni P; Poli A; Fetiveau R; Cafiero F; D'Urbano M; De Servi S Ital Heart J Suppl; 2002 May; 3(5):539-43. PubMed ID: 12064193 [TBL] [Abstract][Full Text] [Related]
5. GP IIB/IIIA blockers with and without thrombolytic agent in prehospital treatment of acute myocardial infarction. Verheugt FW Thromb Res; 2001 Sep; 103 Suppl 1():S113-6. PubMed ID: 11567678 [TBL] [Abstract][Full Text] [Related]
6. Glycoprotein IIb/IIIa antagonism and fibrinolytic therapy for acute myocardial infarction. Vivekananthan DP; Patel VB; Moliterno DJ J Interv Cardiol; 2002 Apr; 15(2):131-9. PubMed ID: 12063808 [TBL] [Abstract][Full Text] [Related]
7. The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends. Campbell KR; Ohman EM; Cantor W; Lincoff AM Am J Cardiol; 2000 Apr; 85(8A):32C-8C. PubMed ID: 10793178 [TBL] [Abstract][Full Text] [Related]
8. Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarction. Hudson MP; Greenbaum AB; Harrington RA; Ohman EM J Thromb Thrombolysis; 1999 Jun; 7(3):241-5. PubMed ID: 10373717 [TBL] [Abstract][Full Text] [Related]
9. Combination therapy for acute myocardial infarction: fibrinolytic therapy and glycoprotein IIb/IIIa inhibition. Califf RM Am Heart J; 2000 Feb; 139(2 Pt 2):S33-7. PubMed ID: 10650314 [TBL] [Abstract][Full Text] [Related]
10. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. Lincoff AM; Califf RM; Van de Werf F; Willerson JT; White HD; Armstrong PW; Guetta V; Gibler WB; Hochman JS; Bode C; Vahanian A; Steg PG; Ardissino D; Savonitto S; Bar F; Sadowski Z; Betriu A; Booth JE; Wolski K; Waller M; Topol EJ; JAMA; 2002 Nov; 288(17):2130-5. PubMed ID: 12413372 [TBL] [Abstract][Full Text] [Related]
11. Administration of glycoprotein IIb-IIIa inhibitors in patients with ST-segment elevation myocardial infarction. Dobesh PP; Kasiar JB Pharmacotherapy; 2002 Jul; 22(7):864-88. PubMed ID: 12126220 [TBL] [Abstract][Full Text] [Related]
12. Role of glycoprotein IIb/IIIa-receptor inhibitors in managing ST-segment-elevation myocardial infarction. Racine E Am J Health Syst Pharm; 2002 Nov; 59(21 Suppl 7):S27-36. PubMed ID: 12434712 [TBL] [Abstract][Full Text] [Related]
13. Targeting the use of platelet IIb/IIIa inhibitors: treatment of acute myocardial infarction. Lincoff AM Rev Cardiovasc Med; 2002; 3 Suppl 1():S13-9. PubMed ID: 12439432 [TBL] [Abstract][Full Text] [Related]